Literature DB >> 22498999

Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus.

Nicolas Lamblin1, Marie Fertin, Pascal de Groote, Christophe Bauters.   

Abstract

AIMS: The mechanisms underlying the higher risk of heart failure after myocardial infarction (MI) in diabetic patients remain incompletely understood. Our aim was to investigate cardiac remodeling after MI according to diabetic status.
METHODS: Data from 512 patients with a first anterior MI included in two prospective cohorts on left-ventricular remodeling were analyzed. Echocardiographic studies were performed before discharge, at 3 months and at 1 year. Clinical follow-up was performed after 3 years.
RESULTS: There were 60 (23%) diabetic patients in cohort 1 and 51 (21%) in cohort 2. Therapeutic strategies, infarct size and residual left-ventricular ejection fraction did not differ between diabetic and nondiabetic patients. In both cohorts, there was a significant increase in left-ventricular volumes and a recovery in left-ventricular systolic function from baseline to 1 year; these parameters did not differ according to diabetic status at any of the three time points. Diastolic function was analyzed in cohort 2: the E/Ea ratio was higher in diabetic patients at baseline and during follow-up. Diabetes mellitus was an independent predictor of cardiovascular death or rehospitalization for heart failure in cohort 1 [relative risk (RR) 2.62 (1.35-5.11)] and in cohort 2 [RR 4.99 (2.06-12.21)].
CONCLUSIONS: In patients with a modern treatment of MI, diabetes mellitus remains a major and independent predictor of subsequent heart failure. This higher risk is not associated with a decreased left-ventricular systolic function or with increased left-ventricular remodeling. The evidence of higher left-ventricular filling pressures suggests left-ventricular diastolic dysfunction as a potential mechanism.

Entities:  

Mesh:

Year:  2012        PMID: 22498999     DOI: 10.2459/JCM.0b013e328353694b

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  14 in total

Review 1.  Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Authors:  Bartosz Walkowski; Marcin Kleibert; Miłosz Majka; Małgorzata Wojciechowska
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

2.  The ceRNA Crosstalk between mRNAs and lncRNAs in Diabetes Myocardial Infarction.

Authors:  Yun Zhou; Chengjun Zhou; Lilong Wei; Chengwu Han; Yongtong Cao
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

Review 3.  Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.

Authors:  Takayuki Miki; Takahito Itoh; Daisuke Sunaga; Tetsuji Miura
Journal:  Cardiovasc Diabetol       Date:  2012-06-13       Impact factor: 9.951

4.  Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts.

Authors:  Raj Kishore; Suresh K Verma; Alexander R Mackie; Erin E Vaughan; Tatiana V Abramova; Ito Aiko; Prasanna Krishnamurthy
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

5.  Amlodipine Ameliorates Ischemia-Induced Neovascularization in Diabetic Rats through Endothelial Progenitor Cell Mobilization.

Authors:  Jiayin Sun; Jun Xie; Lina Kang; Albert Ferro; Li Dong; Biao Xu
Journal:  Biomed Res Int       Date:  2016-05-08       Impact factor: 3.411

6.  The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.

Authors:  Lawien Al Ali; Minke T Hartman; Chris P H Lexis; Yoran M Hummel; Erik Lipsic; Joost P van Melle; Dirk J van Veldhuisen; Adriaan A Voors; Iwan C C van der Horst; Pim van der Harst
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

Review 7.  The Emerging Role of MicroRNA-155 in Cardiovascular Diseases.

Authors:  Richard Y Cao; Qing Li; Yi Miao; Ying Zhang; Wenchao Yuan; Li Fan; Gongliang Liu; Qiongyao Mi; Jian Yang
Journal:  Biomed Res Int       Date:  2016-11-27       Impact factor: 3.411

8.  Long-term prognostic impact of left ventricular remodeling after a first myocardial infarction in modern clinical practice.

Authors:  Christophe Bauters; Emilie Dubois; Sina Porouchani; Eric Saloux; Marie Fertin; Pascal de Groote; Nicolas Lamblin; Florence Pinet
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

9.  Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients.

Authors:  Jia-Yin Sun; Lin Zhai; Qiao-Ling Li; Jia-Xin Ye; Li-Na Kang; Jun Xie; Biao Xu
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

10.  Speckle tracking imaging as a predictor of left ventricular remodeling 6 months after first anterior ST elevation myocardial infarction in patients managed by primary percutaneous coronary intervention.

Authors:  Islam Bastawy; Mohamed Ismail; Hany F Hanna; Wael El Kilany
Journal:  Egypt Heart J       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.